Phoenix Molecular Designs' Seed VC Round

Phoenix Molecular Designs raised a round of funding on September 18, 2018.

Phoenix Molecular Designs is a biotechnology company that is developing small molecule kinase inhibitors as a targeted therapy for cancer. It is focused on treating one of the most aggressive types of…

Articles about Phoenix Molecular Designs' Seed VC Round: